Skip to main content

and
  1. Article

    Open Access

    Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene

    5-fluorouracil pharmacokinetics, dihydropyrimidine dehydrogenase-activity and DNA sequence analysis were compared between a patient with extreme 5-fluorouracil induced toxicity and six control patients with no...

    J G Maring, A B P van Kuilenburg, J Haasjes, H Piersma in British Journal of Cancer (2002)

  2. Article

    Open Access

    Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancer

    Our aim was to study the feasibility of an intensified intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) schedule with the aim to escalate dose intensity (DI). Twenty-three premenopausal brea...

    A M E Bos, H de Graaf, E G E de Vries, H Piersma in British Journal of Cancer (2000)

  3. No Access

    Article

    Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study

    The tolerability and efficacy of four courses of paclitaxel and ifosfamide plus cisplatin every 3 weeks was evaluated in patients with residual or refractory ovarian cancer. Additionally, supportive haematolog...

    GJ Veldhuis, PHB Willemse, JH Beijnen, H Boonstra, H Piersma in British Journal of Cancer (1997)

  4. No Access

    Chapter and Conference Paper

    Combined Generation of Electricity and Power in the Dairy Industry

    The study into the application of Total Energy systems in the dairy industry is restricted to medium size units (about 500 kw) and to the sector of powder manufacture. The power and heat demand of this process...

    L. A. Jansen, H. Piersma in New Ways to Save Energy (1980)